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(57) ABSTRACT 
A novel contrast mechanism for imaging blood flow using 
magneto-motive optical Doppler tomography (MM-ODT), 
Optical Coherence Tomography, and Ultrasound. MM-ODT. 
OCT, and ultrasound combined with an externally applied 
temporally oscillating high-strength magnetic field detects 
erythrocytes moving according to the field gradient. 
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1. 
HEMOGLOBIN CONTRAST IN 
MAGNETO-MOTIVE OPTICAL DOPPLER 
TOMOGRAPHY, OPTICAL COHERENCE 
TOMOGRAPHY, AND ULTRASOUND 
MAGING METHODS AND APPARATUS 
FUNDING 
This invention was supported by funds from the National 
Institutes of Health (AR47551, EB002495 and EB002021) 
and the Texas Advanced Technology Program. The U.S. Gov 
ernment may have certain rights in the invention. 
BACKGROUND 
The present invention relates in general to the art of medi 
cal diagnostic imaging and in particular to imaging blood 
flow using magneto-motive optical Doppler tomography 
(MM-ODT), Optical Coherence Tomography, or Ultrasound, 
which combines an externally applied temporally oscillating 
high-strength magnetic field with ODT. OCT, or Ultrasound 
to detect erythrocytes moving according to the field gradient. 
The accurate determination of location and flow velocity of 
moving particles in highly scattering media, Such as blood 
flow, is important for medical diagnostics. While the mea 
Surements of blood flow in the coronary arteries is an impor 
tant aspect in diagnosing coronary artery diseases. Numerous 
non-invasive approaches have been developed using tech 
niques such as Doppler ultrasound, conventional angiogra 
phy, laser Doppler flowmetry and magnetic resonance 
angiography. 
One common sensing technique involves the use of ultra 
Sound. Using this technique, ultrasound is directed into the 
body of the patient and tiny particles such as red blood cells, 
which are Suspended in the blood plasma, scatter the ultra 
Sonic energy back towards the receiver or transducer. The 
transducer then converts the back-scattered ultrasonic energy 
into an electrical signal that is processed in Some known 
manner to determine the presence of a flow and an estimate of 
the flow velocity. 
Magnetic resonance imaging (MRI) is based on an imaging 
technique for magnetically exciting nuclear spins in a subject 
positioned in a static magnetic field by applying a radio 
frequency (RF) signal of the Larmor frequency, and recon 
structing an image using MR signals induced by the excita 
tion. MRI is widely applied inclinical medicine because of its 
capability of clearly depicting the slightest tissue of human 
brain in vivo. 
Magnetic resonance angiography (MRA) provides 
detailed angiographic images of the body in a non-invasive 
manner. In conventional MRA, which does not use contrast 
agents, magnetic resonance signal from flowing blood is opti 
mized, while signal from stationary blood or tissue structures 
is Suppressed. In contrast-enhanced MRA, a contrast agent is 
injected into the blood stream to achieve contrast between 
flowing blood and stationary tissue. 
The commonly known echo planar imaging (EPI) is a rapid 
MRI technique, which is used to produce tomographic 
images at high acquisition rates, typically several images per 
second. Functional magnetic resonance imaging (fMRI) has 
been found useful in perfusion and/or diffusion studies and in 
dynamic-contrast studies, etc. However, images obtained in 
EPI experiments tend to be vulnerable to an artifact known as 
“ghosting or 'ghost images.” 
Optical coherence tomography (OCT) is a technology that 
allows for non-invasive, cross-sectional optical imaging of 













tivity. OCT is an extension of low-coherence or white-light 
interferometry, in which a low temporal coherence light 
source is utilized to obtain precise localization of reflections 
internal to a probed structure along an optic axis. This tech 
nique is extended to enable scanning of the probe beam in the 
direction perpendicular to the optic axis, building up a two 
dimensional reflectivity data set, used to create a cross-sec 
tional gray-scale or false-color image of internal tissue back 
Scatter. 
OCT uses the short temporal coherence properties of 
broadband light to extract structural information from hetero 
geneous samples Such as biologic tissue. OCT has been 
applied to imaging of biological tissue in vitro and in vivo. 
Systems and methods for Substantially increasing the resolu 
tion of OCT and for increasing the information content of 
OCT images through coherent signal processing of the OCT 
interferogram data have been developed to provide cellular 
resolution (i.e., in the order of 5 micrometers). During the past 
decade, numerous advancements in OCT have been reported 
including real-time imaging speeds. 
In diagnostic procedures utilizing OCT, it would also be 
desirable to monitor the flow of blood and/or other fluids, for 
example, to detect peripheral blood perfusion, to measure 
patency in Small vessels, and to evaluate tissue necrosis. 
Another significant application would be in retinal perfusion 
analysis. Accordingly, it would be advantageous to combine 
Doppler flow monitoring with the above micron-scale reso 
lution OCT imaging in tissue. 
Conventional OCT imaging primarily utilizes a single 
backscattering feature to display intensity images. Functional 
OCT techniques process the backscattered light to provide 
additional information on birefringence, and flow properties. 
(See for example, Kemp NJ, Park J, Zaatar HN, Rylander H 
G. Milner T. E. High-sensitivity determination of birefrin 
gence in turbid media with enhanced polarization-sensitive 
optical coherence tomography, Journal of the Optical Society 
of America A: Optics Image Science and Vision 2005, 22(3): 
552-560; Dave DP, Akkin T. Milner TE, Polarization-main 
taining fiber-based optical low-coherence reflectometer for 
characterization and ranging of birefringence, Optics Letters 
2003, 28(19): 1775-1777: Rylander CG, Dave DP, Akkin T, 
Milner TE, Diller KR, Welch M. Quantitative phase-contrast 
imaging of cells with phase-sensitive optical coherence 
microscopy, Optics Letters 2004, 29(13):1509-1511; de Boer 
J. F. Milner T E, Ducros M G, Srinivas S M, Nelson J S. 
Polarization-sensitive optical coherence tomography, Hand 
book of Optical Coherence Tomography, New York: Marcel 
Dekker, Inc., 2002, pp. 237-274.) 
Since the ability to characterize fluid flow velocity using 
OCT was demonstrated by Wang et al., several phase 
resolved, real-time optical Doppler tomography (ODT) 
approaches have been reported. (See for example, Chen Z. P. 
Milner T. E. Dave D, Nelson J S. Optical Doppler tomo 
graphic imaging of fluid flow velocity in highly scattering 
media, Optics Letters 1997, 22(1):64-66: Wang XJ, Milner T 
E, Nelson J S. 
Optical Doppler tomography (ODT) combines Doppler 
velocimetry with optical coherence tomography (OCT) for 
noninvasive location and measurement of particle flow veloc 
ity in highly scattering media with micrometer-scale spatial 
resolution. The principle employed in ODT is very similar to 
that used in radar, Sonar and medical ultrasound. ODT uses a 
low coherence or broadband light source and optical interfer 
ometer to obtain high spatial resolution gating with a high 
speed scanning device Such as a conventional rapid scanning 
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optical delay line (RSOD) to perform fast ranging of micro 
structure and particle motion detection in biological tissues or 
other turbid media. 
To detect the Doppler frequency shift signal induced by the 
moving particles, several algorithms and hardware schemes 
have been developed for ODT. The most straightforward 
method to determine the frequency shift involves the use of a 
short time fast Fourier transform (STFFT). However, the 
sensitivity of this method is mainly dependent on the FFT 
time window, which limits axial scanning speed and spatial 
resolution when measuring slowly moving blood flow in 
small vessels that requires high velocity sensitivity. However, 
a phase-resolved technique can decouple the Doppler sensi 
tivity and spatial resolution while maintaining high axial 
Scanning speed. 
In ODT, the Doppler frequency shift is proportional to the 
cosine of the angle between the probe beam and the scatter 
er's flow direction. When the two directions are perpendicu 
lar, the Doppler shift is zero. Because a priori knowledge of 
the Doppler angle is not available, and conventional intensity 
OCT imaging provides a low contrast image of microvascu 
lature structure, detecting small vessels with slow flow rates is 
difficult. However, the Doppler angle can be estimated by 
combining Doppler shift and Doppler bandwidth measure 
ments. (See for example, Piao D Q, Zhu Q, Quantifying 
Doppler Angle and Mapping FlowVelocity by a Combination 
of Doppler-shift and Doppler-bandwidth Measurements in 
Optical Doppler Tomography, Applied Optics, 2003, 42(25): 
5158-5166, and U.S. Pat. No. 5,991,697 describe a method 
and apparatus for Optical Doppler Tomographic imaging of a 
fluid flow in a highly scattering medium comprising the steps 
of scanning a fluid flow sample with an optical source of at 
least partially coherent radiation through an interferometer, 
which is incorporated herein by reference). 
The ability to locate precisely the microvasculature is 
important for diagnostics and treatments requiring character 
ization of blood flow. Recently, several efforts to increase 
blood flow contrast mechanisms have been reported includ 
ing protein microspheres incorporating nanoparticles into 
their shells, plasmon-resonant gold nanoshells, and use of 
magnetically Susceptible micrometer sized particles with an 
externally applied magnetic field. (See for example, Lee TM, 
Oldenburg AL, Sitafalwalla S, Marks DL, Luo W. Toublan F 
JJ, Suslick KS, Boppart SA, Engineered microsphere con 
trast agents for optical coherence tomography, Optics Letters, 
2003, 28(17): 1546-1548; Loo C, Lin A, Hirsch L. Lee MH, 
Barton J. Halas N, West J. Drezek R. Nanoshell-enabled 
photonics-based imaging and therapy of cancer. Technology 
in Cancer Research & Treatment, 2004; 3(1): 33-40; and 
Oldenburg AL, Gunther JR, Boppart SA, Imaging magneti 
cally labeled cells with magnetomotive optical coherence 
tomography, Optics Letters, 2005, 30(7): 747-749.) 
Wang, et al., “Characterization of Fluid Flow Velocity by 
Optical Doppler Tomography. Optics Letters, Vol. 20, No. 
11, Jun. 1, 1995, describes an Optical Doppler Tomography 
system and method which uses optical low coherence reflec 
trometry in combination with the Doppler effect to measure 
axial profiles of fluid flow velocity in a sample. A disadvan 
tage of the Wang system is that it does not provide a method 
to determine direction of flow within the sample and also does 
not provide a method for generating a two-dimensional color 
image of the sample indicating the flow velocity and direc 
tions within the image. 
The use of an externally applied field to move magnetically 
Susceptible particles in tissue has been termed magneto-mo 
tive OCT (MM-OCT). Functional magnetic resonance imag 














netic molecule. However, the paramagnetic Susceptibility of 
human tissue is very low compared to other biocompatible 
agents such as ferumoxides (nanometer sized iron oxide par 
ticles). Therefore, it was believed that, other than differenti 
ating relaxation times (T2) between oxygenated and deoxy 
genated blood, the magnetic field strength required to 
produce a retarding force on blood flow was well above that of 
current imaging fields. (See also, for example, Schenck J. F., 
Physical interactions of static magnetic fields with living 
tissues, Progress in Biophysics and Molecular Biology 2005, 
87(2-3):185-204; and Taylor DS, Coryell, C. D., Magnetic 
susceptibility of iron in hemoglobin. J. Am. Chem. Soc. 1938, 
60.1177-1181.) 
The present invention is a novel extension of MM-OCT to 
image hemoglobin in blood erythrocytes. In one aspect of the 
invention, the approach requires no exogenous contrast agent 
to detect blood flow and location. 
SUMMARY OF THE INVENTION 
The invention is a method and apparatus of imaging a blood 
flow using Doppler optical coherence tomography, which 
comprises an externally applied temporally oscillating high 
strength magnetic field with a Doppler optical tomography 
system to detect hemoglobin moving according to the mag 
netic field gradient. 
In another embodiment, the invention comprises a Solenoid 
cone-shaped ferrite core with an extensively increased mag 
netic field strength at the tip of the core. In a further embodi 
ment, the invention comprises focusing the magnetic force on 
targeted samples. 
Another embodiment is an apparatus for imaging blood 
flow, comprising: (1) a magnetomotive optical Doppler 
tomography (MM-ODT) imaging system; (2) an oscillating 
magnetic field applied to the moving blood flow; (3) a light 
Source (4) a rapid scanning optical delay line in a reference 
arm and aligned Such that no phase modulation is generated 
when the group phase delay is scanned at 4 kHz; and (5) a 
hardware in-phase and a quadrature demodulator with high 
bandpass filters. 
Another aspect of the invention is a method for imaging a 
blood flow, comprising applying a magnetic field to the blood 
flow, wherein the blood flow comprising a plurality of hemo 
globin molecules and wherein the magnetic field interacts 
with the hemoglobin molecules to cause a change in the blood 
flow; and detecting the blood flow by detecting the change in 
the blood flow caused by the interaction with the hemoglobin 
molecules, wherein the change is detected using a magneto 
motive optical Doppler tomography imaging system. 
Another embodiment of the method for imaging a blood 
flow comprises temporally oscillating the magnetic field. 
Another embodiment of the invention is an apparatus for 
imaging a blood flow comprising a magnetic field generator 
for applying a magnetic field to the blood flow, wherein the 
blood flow comprises hemoglobin molecules; and an ultra 
sound detection system for detecting the blood flow while it is 
in the presence of the magnetic field. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a schematic diagram of the MM-ODT system. 
FIG. 2 is a schematic diagram of the probe beam, flow 
sample and Solenoid coil. 
FIGS. 3a and 3b are OCT and ODT images of a stationary 
turbid solution without an external magnetic field, respec 
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tively. FIG.3c and FIG. 3d are OCT and ODT images with a 
50 Hz, magnetic field, respectively. The white bar represents 
200 um, accordingly. 
FIGS. 4a-4d are M-mode ODT images of the diluted 
deoxygenated blood flow (18%hematocrit) without and with 
an external magnetic field. FIG. 4a and FIG. 4b are ODT 
images of 5 mm/s blood flow without and with a 5 Hz mag 
netic field, respectively. FIG. 4c and FIG. 4d are ODT images 
of 30 mm/s blood flow without and with a 50 Hz, magnetic 
field, respectively. The Black bar indicates 200 um, accord 
ingly. 
FIG. 5a and FIG. 5b are the Doppler frequency shift pro 
files without an external magnetic field, and with a 50 Hz 
magnetic field, respectively. 
FIG. 6 is a block diagram illustrating an exemplary phase 
sensitive OCT system. 
FIG. 7 is a graph of the optical path length change in the 
DP-OCT system. 
FIG. 8 is a schematic diagram of Magneto Motive Ultra 
sound for Blood. 
FIG. 9 is an ultrasound image of blood exposed to an 
oscillating magnetic field. 
FIG. 10 is a schematic diagram of Ultrasonography and 
OCT coupled with magnetic field generator. 
DETAILED DESCRIPTION OF THE INVENTION 
Magneto-Motive Optical Doppler Tomography (MM 
ODT) for improved Doppler imaging of blood flow using an 
external oscillating magnetic field is described below. By 
introducing mechanical movement of red blood cells 
(RBC's) during blood flow by a temporally oscillating high 
strength magnetic field, MM-ODT allows imaging of blood 
flow and velocity. The controlled and increased Doppler fre 
quency in MM-ODT provides an investigational tool to study 
in vivo blood transport, as shown in the article Hemoglobin 
Contrast in Magnetomotive Optical Doppler Tomography, 
Opt. Lett. 31, 778-780 (2006), herein incorporated by refer 
CCC. 
The microstructure of the blood flow and flow velocity 
information are all encoded in the interferogram of a Doppler 
OCT system. It should be readily apparent to those skilled in 
the optical arts, that different OCT systems and different OCT 
information can be used to determine the Doppler frequency 
shift. It is not intended to suggest any limitation as to the 
scope or functionality with different OCT architectures or 
optical information used with an oscillating magnetic field, 
such as time domain Doppler OCT and spectral domain Dop 
pler OCT. Time domain OCT requires a mirror in the refer 
ence arm Scanning at a constant Velocity, while spectral 
domain OCT includes swept source OCT and Fourier domain 
OCT. An example of time-domain Doppler OCT is provided 
below. 
A schematic of the MM-ODT apparatus 10 is shown in 
FIG.1. The OCT light source 12 comprises a super lumines 
cent diode, which is used as the low coherence light Source. In 
one embodiment, light source 12 is centered at 1.3 um with a 
bandwidth of 90 nm. Light from source 12 is coupled into a 
single-mode optical fiber based interferometer 20 by circula 
tor 14, where the interferometer 20 can provide 1 mW of 
optical power at the sample 60. Light is split into a reference 
arm 22 and sample arm 24 by a 2x2 splitter 16. A rapid 
scanning optical delay (RSOD) line 26 is coupled to the 
reference arm 22. In one embodiment, the rapid-scanning 
optical delay line 26 is aligned such that no phase modulation 
is generated when the group phase delay is scanned at ~4 kHz. 














sample 60 by two galvanometers 30 that permit three-dimen 
sional scanning. In one embodiment, the galvanometers can 
be an X-scanner and a Y-scanner. The sample 60 can be 
internal or external to the body, where the probe beam is 
focused by an objective lens 32. In one embodiment, the 
objective lens 32 yields a 10-um spot at the focal point. Phase 
modulation can be generated using an electro-optical 
waveguide phase modulator, which can produce a carrier 
frequency (~1 MHz). And the magnetic field generator 100 is 
in proximity to the sample 60. 
A dual-balanced photodetector 34 is coupled to the 2x2 
splitter 16 and the circulator 14. The photodetector 34 of a 80 
MHz bandwidth reduces the light source noise from the OCT 
interference signal. A hardware in-phase and quadrature 
demodulator 40 with high/bandpass filters 42 and low/band 
pass filters 44 improves imaging speed. Doppler information 
was calculated with the Kasai autocorrelation velocity esti 
mator. Labview software 50 (National Instruments, Austin, 
Tex.) is coupled to the MM-ODT system with a dual proces 
Sor based multitasking scheme. The maximum frame rate of 
the MM-ODT system 10 was 16 frames per second for a 
400x512 pixel sized image. The Doppler frequency shift can 
be determined with the use of a short time fast Fourier trans 
form (STFFT). Alternatively, a phase-resolved technique can 
determine the Doppler frequency shift to decouple the Dop 
pler sensitivity and spatial resolution while maintaining high 
axial scanning speed. Alternatively, differential phase optical 
coherence tomography (OCT) or spectral domain phase-sen 
sitive OCT can be used to determine the Doppler frequency 
shift, as readily determined by one skilled in the optical arts. 
FIG.2 shows an example of the magnetic field generator 80 
with a capillary tube 90. The magnetic field generator 80 
includes a solenoid coil 82 (Ledex 4EF) with a cone-shaped 
ferrite core 84 at the center and driven by a current amplifier 
86 supplying up to 960 W of power. The magnetic field 
generator 80 can be placed underneath the sample 60 during 
MM-ODT imaging. The combination of the ferrite core 84 
and Solenoid coil 82 using a high power operation dramati 
cally increases the magnetic field strength (B, 0.14 Tesla) 
at the tip of the core 82 and also focuses the magnetic force on 
the targeted samples 60. The sinusoidal current can vary the 
magnetic force applied to the capillary tube 90 in order to 
introduce movement of magnetic fluids, which include red 
blood cells that contain hemoglobin. In one embodiment, the 
probe beam is oriented parallel to the gradient of the magnetic 
field's strength. 
The material parameter characterizing magnetic materials, 
including biological tissue, is the magnetic Volume suscepti 
bility, X. Magnetic Volume Susceptibility is dimensionless in 
SI units and is defined by the equation M-H, where M is the 
magnetization at the point in question and H is the local 
density of the magnetic field strength. Hemoglobin's high 
iron content, due to four Fe atoms in each hemoglobin mol 
ecule, and the large concentration of hemoglobin in human 
red blood cells give Hemoglobin magneto-motive effects in 
biological tissue. The magnetic Volume Susceptibility of the 
hemoglobin molecule consists of a paramagnetic component 
due to the electron spins of the four iron atoms. The paramag 
netic susceptibility is given by the Curie Law, 
HoNp (unki) (1) 
where L is permeability of free space and has the value 
4tx107 H/m, N is the volume density of paramagnetic iron 
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atoms in hemoglobin, N-4.97x10° ironatoms/m. legis the 
effective number of Bohr magnetons per atom reported as 
5.35, and the Bohr magneton, L-9.274x10''J/T, and Bolt 
Zmann's constant, k=1.38x10 J/K, and T is the absolute 
temperature (K). The calculated susceptibility of a RBC is 
about 11x10' assuming a 90% concentration of hemoglobin 
per RBC. The calculated susceptibility of a RBC is dependent 
on the oxygenation of the hemoglobin. The calculations can 
be adjusted accordingly, depending on the oxygenation of the 
RBC, which can be measured by known techniques. 
A RBC placed in a magnetic field gradient experiences 
forces and torques that tend to position and align it with 
respect to the field's direction. The magnetic force, in the 
direction of the probing light Z, is given by 
o:(t) oU A Vob (2) 
where V is the particle Volume, B is the magnitude of the 
magnetic flux density, and AX is the difference between the 
Susceptibility of the particle and the Surrounding medium. 
The displacement Z(t) of an RBC driven by a time varying 
magnetic flux density can be included in the analytic OCT 
fringe expression, Ia 
(3) 
If a2 Ilex (2 ft + lso Ao 
where I and Is are the back scattered intensities from the 
reference and sample arms, respectively, f is the fringe car 
rier frequency, w is the center wavelength of the light source, 
and Z(t) is the RBC displacement. Integration of all forces 
(magnetic, elastic, and Viscous) on the RBC gives displace 
ment, Z(t) A cos(47tfit) where A is a constant in units of 
length and f is the modulation frequency of the magnetic 
flux density. In free space, the displacement, Z(t), is domi 
nated a constant acceleration which can be, however, ignored 
in confined models (i.e. blood vessel or capillary tube) with 
assumptions that, first, the probing area is much smaller than 
magnetic field area, and that secondly probing time starts 
after steady states of inner pressures. Expansion of the right 
hand side of Eq. (3) using Bessel functions gives 
If a 2v IRIs (4) 
exp(i27tfit 
where J(m) is the Bessel function of the first kind of orderk 
for argument m which is 4. LA/). The amplitude of the k" 
sideband is proportional to J. (m). In coherent detection, the 
fraction of optical power transferred into each of the first 
order sidebands is (J/(m)), and the fraction of optical power 
that remains in the carrier is (J.(m)). 
EXAMPLE1 
MM-ODT Imaging of the Doppler Shift of Hemoglobin by 














M-mode OCT/ODT images of a capillary glass tube filled 
with a stationary turbid solution with and without an external 
magnetic field as a control sample were recorded, as shown in 
FIGS. 3-4. A 750 um-inner diameterglass capillary tube 200 
was placed perpendicularly to the probing beam 70, as shown 
in FIG. 2. Fluids used for flow studies were injected through 
the tube at a constant flow rate controlled by a dual-syringe 
pump (Harvard Apparatus 11 Plus, Holliston, Mass.) with 
+0.5% flow rate accuracy. The turbid solution was a mixture 
of deionized water and 0.5-gm latex microspheres (15 
mm). The magnetic flux density and its frequency were 
approximately 0.14T and 50 Hz, respectively. M-mode OCT/ 
ODT images were acquired for 100 ms per frame. FIGS. 3a 
and 3b show M-mode OCT and ODT images without any 
external magnetic field, respectively. The ODT image in FIG. 
3b contains Small random phase fluctuations due to ambient 
vibration through the optical path. FIGS. 3c and 3d show 
M-mode OCT and ODT images with a 50 Hz external mag 
netic field, respectively. No distinguishable Doppler shift 
could be observed in the ODT image FIG. 3d indicating no 
interaction between the external magnetic field and the mov 
ing microspheres. 
Deoxygenated blood was extracted from the vein of a 
human male’s left arm, and diluted with Saline. During prepa 
ration, blood was not exposed directly to air so as to remain 
deoxygenated. To simulate flow, blood was injected through 
the capillary tube 200 by a syringe pump at a relatively 
constant flow rate. As FIG. 4 shows, the oscillating Doppler 
frequency shift, resulting from RBC movement, could be 
observed at two different flow rates (5 and 30 mm/s). Because 
the flow direction was nearly perpendicular to the probing 
beam no significant Doppler frequency shift was distinguish 
able at the 5 mm/s flow rate FIG. 4a without any external 
magnetic field. In the case of the high blood flow rate of 30 
mm/s, as shown at FIG. 4c, the Doppler frequency shift 
caused by the blood flow could be observed. And for maxi 
mum contrast enhancement, the probe beam can be directed 
parallel to the gradient of the magnetic field's strength. How 
ever, application of a 50 Hz magnetic field increased the 
Doppler contrast of blood at both the slow and fast flow rates 
as shown at FIGS. 4b and 4d. The high flow rate of 30 mm/s 
gives a higher contrast image than the low flow rate image, but 
the Doppler frequency shift of the former as a function of 
depth is less homogeneous than the latter, which is indicative 
of perturbation by blood flow. The same blood was diluted to 
5% hematocrit (HCT), but no RBC movement could be 
observed below 8% HCT. 
Doppler frequency shift profiles were calculated from the 
ODT images by averaging 20 lines at a selected depth indi 
cated by horizontal arrows, as shown in FIGS. 4a and 4b. FIG. 
5a indicates no significant Doppler frequency shift over a 100 
ms time period, whereas FIG. 5b displays +200 to 300 Hz 
Doppler frequency shifts oscillating 20 times over 100 ms 
(200 Hz). 
The Doppler frequency shift indicates that RBC's physi 
cally move into and away from the incident light while pass 
ing through the external magnetic field depending on whether 
their magnetic properties are paramagnetic or diamagnetic, as 
shown in FIG. 4, and that the 200 Hz oscillation of the Dop 
pler frequency shift correlates with the 50 Hz, magnetic field, 
as shown in FIG.5. Frequencies 4 times higher than that of the 
external magnetic field (f) can be observed. According to 
Eq. 2, the frequency of the force on paramagnetic targets was 
twice that of the magnetic flux density; therefore, a 50 Hz, B 
field displaces the targets at 100 Hz. Although the fringe 
signal (Eq. 4) contains harmonics at frequency (2f ), the 
modulation frequency, f, was set so that the second-order r 
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sideband (4f) was dominant as shown in FIG. 5b. The par 
ticle motion cannot be described as a pure sinusoidal function 
even if the modulated magnetic field is sinusoidal, due to the 
numerous forces that contribute to the motion within the field 
Such as gravity, concentration gradient, and colloidal disper 
S1O. 
The invention is a new investigational tool to study in vivo 
blood transport and the first implementation of MM-ODT for 
improved Doppler imaging of blood flow using an external 
oscillating magnetic field introducing a mechanical move 
ment of RBCs during blood flow by a temporally oscillating 
high-strength magnetic field. MM-ODT to allow imaging of 
tissue function in a manner similar to functional magnetic 
resonance images (f-MRI) of deoxygenated blood in organs, 
when the sample arm of the MM-ODT system is coupled to a 
probe (not shown). Such probes are generally known in the 
arts, such as endoscopic probes, catheter probes, and the like. 
Alternatively, the MM-ODT can be used for Port-Wine 
vessel mapping and Skin Cancer vessel mapping. The MM 
ODT can be used to detect blood vessel location and size for 
cancer and port-wine stains, since these conditions are char 
acterized by blood vessel growth and increases in hemoglobin 
content. Accordingly, other blood vessel detection for tissue 
abnormality identification can be envisioned with this inven 
tion. Generally, the MM-ODT can be used wherever blood 
flow detection is necessary in operations, chemotherapy, 
hemodialysis, and the like. 
A spectral domain phase sensitive OCT system 100 can be 
used to image the blood flow and determine velocity infor 
mation, when an oscillating magnetic field is applied to the 
blood flow, as shown in FIG. 6. Spectral domain phase sen 
sitive OCT generally uses a broadband light source in a gen 
eral interferometric setup, where the mirror in the reference 
typically does not move or does not require a rapid scanning 
delay line. A spectral interferogram is detected, in which each 
A-scan is entirely encoded. A Fourier transformation of the 
A-scan and velocity distribution of the blood flow can be 
extracted by known methods. In spectral domain Doppler 
OCT, the blood flow profile is the envelope of a calculated 
A-Scan through Fourier transformation on the spectral inter 
ferogram. Velocity information is encoded in the phase of the 
interferogram. The Doppler velocity can be extracted by mea 
Suring the phase shift between two Successive calculated 
A-scans in spectral domain Doppler OCT. 
This OCT system 100 is only an example of one OCT 
imaging modality which can be used to image blood flow with 
a temporally oscillating magnetic field, and is not intended to 
Suggest any limitation on the scope of OCT architectures 
applicable to the invention. Generally, the OCT system 100 
includes a general-purpose computing device in the form of a 
computer 101 and includes a magnet control 114 and a mag 
net 116. 
Light energy is generated by a light source 117. The light 
source 117 can be abroadband laser light source coupled into 
optical fiber emitting light energy over a broad range of opti 
cal frequencies. The wavelength range can be from about 400 
nanometers to about 1400 nanometers. Longer wavelengths 
(>600 nm) can be used for deeper scanning. Preferably, the 
light source emits light having a wavelength near the infrared 
spectrum to identify hemoglobin for OCT imaging, which 
places hemoglobin in motion and increases optical scattering 
of the hemoglobin. The light energy can be emitted over a 
multiplicity of optical wavelengths, frequencies, and pulse 
durations to achieve OCT imaging. As used herein, optical 
fiber can refer to glass or plastic wire or fiber. Optical fiber is 
indicated on FIG. 6 as lines connecting the various blocks of 













“traveling,” “returning.” “directed,” or similar movement, 
Such movement can be via optical fiber. 
A fraction of the generated light energy passes from the 
light source 117 into an optical spectrum analyzer 118. The 
optical spectrum analyzer 118 measures optical frequency as 
the light energy is emitted from the light source 117 as a 
function of time. The optical spectrum analyzer 118 samples 
a portion of the light emitted by the light source 117. The 
optical spectrum analyzer 118 monitors the power spectral 
density of light entering the splitter 119. The remaining frac 
tion of light energy from the light source 117 passes into a 
splitter 119. The splitter 119 can be a device with four ports, 
with Port 1 allowing light energy to enter the splitter 119. 
Ports 2 and 3 allow light energy to leave and re-enter the 
splitter 119 to the reference reflector 120 and OCT probe 122, 
respectively. Port 4 allows light energy to leave the splitter 
119 to coupling lens 124. The splitter 119 couples the light 
into Port 1. The splitter 119 divides the light according to a 
pre-determined split ratio selected by a user. For example, the 
split ratio can be 50/50 wherein half of the light energy 
entering the splitter 119 at Port 1 exits the splitter 119 through 
Port 2 and half exits the splitter 119 through Port 3. In another 
example, the split ratio can be 60/40 wherein 60% of the light 
energy passes through Port 2 and 40% of the light energy 
passes through Port 3. 
A fraction of the light energy (determined by the split ratio) 
that exits the splitter 119 through Port 2 travels to a reference 
reflector surface 120. The light energy is reflected from the 
reference reflector surface 120 back to the splitter 119 into 
Port 2. The reference reflector 120 can be a planar metallic 
mirror or a multilayer dielectric reflector with a specified 
spectral amplitude/phase reflectivity. The remaining fraction 
of light that entered splitter 119 through Port 1 exits splitter 
119 through Port 3 and enters an OCT probe 122. The OCT 
probe 122 can be a turbine-type catheter as described in 
Patent Cooperation Treaty application PCT/US04/12773 
filed Apr. 23, 2004 which claims priority to U.S. provisional 
application 60/466.215 filed Apr. 28, 2003, each herein incor 
porated by reference for the methods, apparatuses and sys 
tems taught therein. The OCT probe 122 can be located within 
a subject 121 to allow light reflection off of subject's 121 
blood flow. 
The light energy that entered OCT probe 122 is reflected 
off of the blood flow of subject 121 once an oscillating mag 
netic field has been temporally applied by magnet 116. The 
reflected light energy passes back through the OCT probe 122 
into the splitter 119 via Port 3. The reflected light energy that 
is returned into Port 2 and Port 3 of the splitter 119 recom 
bines and interferes according to a split ratio. The light recom 
bines either constructively or destructively, depending on the 
difference of pathlengths. A series of constructive and 
destructive combinations of reflected light create an interfero 
gram (a plot of detector response as a function of optical path 
length difference). Each reflecting layer from the subject 121 
and the blood flow will generate an interferogram. The splitter 
119 can recombine light energy that is returned through Port 
2 and Port 3 so that the light energies interfere. The light 
energy is recombined in the reverse of the split ratio. For 
example, if a 60/40 split ratio, only 40% of the light energy 
returned through Port 2 and 60% of the light energy returned 
through Port 3 would be recombined. The recombined 
reflected light energy is directed out Port 4 of the splitter 119 
into a coupling lens 137. The coupling lens 137 receives light 
from the output of the splitter 119 and sets the beam etendue 
(beam diameter and divergence) to match that of the optical 
spectrometer 138. The coupling lens 137 couples the light 
into an optical spectrometer 138. The optical spectrometer 
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138 can divide the recombined reflected light energy light 
into different optical frequencies and direct them to different 
points in space which are detected by a line scan camera 139. 
The line scan camera 139 performs light to electrical trans 
duction resulting in digital light signal data 108. The digital 
light signal data 108 is transferred into the computer 101 via 
the OCT input interface 111. Interface between the line scan 
camera 139 and computer 101 can be a Universal Serial Bus 
(USB), or the like. The digital light signal data 108 can be 
stored in the mass storage device 104 or system memory 112 
and utilized by the image construction software 106 and the 
Labview image construction software 107. 
The image construction Software 106 can generate an 
image of the blood flow of subject 121 from the light signal 
data 108, by receiving light signal data 108 generating ampli 
tude and phase data. The amplitude and phase data (optical 
path length difference (ct) or optical time-delay (t)) can be 
separated into discrete channels and a plot of intensity Vs. 
depth (or amplitude VS. depth) can be generated for each 
channel. Such plot is known as an A-Scan, where the compo 
sition of all the A-scans can comprise one image. And move 
ment image construction Software 107 generates an image of 
the movement of the hemoglobin from the light signal data 
108. The movement image construction software 107 
receives light signal data 108 for at least two successive 
sweeps of the light source 117 or the light source performs a 
Fourier transform on the light signal data 108 generating 
amplitude and phase data. 
Optionally, additional information can be extracted from 
the light signal data to generate additional images. The light 
signal data can be further processed to generate a Stokes 
parameter polarimetric image when used in conjunction with 
polarization detectors and polarizing lenses to extract polar 
ization data from the light signal 108, as readily known to one 
skilled in the art of optical coherence tomography. The dif 
ferential phase OCT image data is shown in FIG.7, indicating 
the optical path difference with the magnetic field. Filters can 
be added to reduce the noise of the signal generated by the 
magnetic field. 
Alternatively, the phase sensitive OCT system 100 can be 
configured for swept source OCT, which is a different type of 
spectral domain OCT. In swept source OCT, a tunable laser 
source replaces the broadband laser light source 117. The 
scanning rate can be at wavelengths of 800 nm-1500 nm. 
Also, the reference reflector surface 120 is in-line with 
sample path 120. The optical spectrometer 125 and line scan 
camera 126 are replaced with a general photodetector. 
In another embodiment, an enhanced detection of cancer 
with ultrasound imaging 200 is provided. Ultrasonography is 
the ultrasound-based diagnostic imaging technique used to 
visualize muscles and internal organs, their size, structures 
and any pathological lesions. “Ultrasound' applies to all 
acoustic energy with a frequency above human hearing (20. 
000 Hertz or 20 kilohertz). Typical diagnostic sonography 
scanners operate in the frequency range of 2 to 13 megahertz, 
hundreds of times greater than this limit. The choice of fre 
quency is a trade-offbetween the image spatial resolution and 
penetration depth into the patient, with lower frequencies 
giving less resolution and greater imaging depth. Doppler 
ultrasonography uses the Doppler Effect to assess whether 
blood is moving towards or away from a probe, and its relative 
Velocity. By calculating the frequency shift (u) of a particu 
lar sample volume, for example a jet of blood flow over a heart 
valve, its speed and direction can be determined and visual 
ized. Ultrasonagraphy and Doppler Ultrasonagraphy can best 
be understood by S. A. Kana Introduction to physics in mod 













the Doppler effect involving acoustic and electromagnetic 
waves of OCT is similar and many of the signal processing 
techniques (hardware and Software) used to estimate the Dop 
pler shift is analogous. 
In one embodiment of the invention, an ultrasound probe 
212 is coupled with the magnetic field generator 100, as 
shown in FIG.8. Ultrasound 210 is directed into the body of 
the patient by known techniques and the moving red blood 
cells backscatter the ultrasonic energy back towards the trans 
ducer of the ultrasound. The oscillating magnetic field gen 
erated by the magnetic field generator 100 increases the con 
trast of the ultrasonic energy 210 received from the red blood 
cells. The transducer then converts the back-scattered ultra 
Sonic energy 210 into an electrical signal that is processed in 
Some known manner to determine an estimate of the flow. An 
enhanced ultrasound image is produced, as displayed in FIG. 
9. 
In one example, a rectal ultrasound probe is coupled with a 
magnet to evaluate the prostate gland for cancer. Currently, 
ultrasound is used for prostate cancer screening; however, the 
approach provides poor sensitivity and specificity. Yet, all 
cancers are known in the art to be highly vascular, so then the 
application of the magnetic field by generator 100 coupled 
with ultrasound enhances the contrast available from the 
endogenous RBC's in the prostate for cancer detection at an 
earlier stage. It is generally known in the art that cancers have 
enhanced metabolic properties compared to normal tissues, 
so then cancerous cells have higher oxygen content from 
hemoglobin and a greater concentration of deoxygenated 
hemoglobin compared to normal tissues. An exemplary ultra 
Sound image for prostate cancer screening is shown in FIG.9. 
MM-ODT, OCT, and ultrasound coupled with an oscillat 
ing magnetic field all can be used in clinical management of 
patients who need microvasculature monitoring, as shown in 
FIG. 10. The images could monitor and determine tissue 
profusion and viability before, during and after operation 
procedures. For example, the images could be used to detect 
oxygenated and deoxygenated blood Supply, detect blood 
vessel location, sizes of cancer, vascular tissue abnormality 
identification, and port-wine stain. Alternatively, the images 
could monitor photodynamic therapy or evaluate cranial inju 
ries. While medical applications of the invention have been 
described, the embodiments of the invention are applicable to 
any circumstance where image contrast is needed for fluids 
comprising endogenous metallic compositions. MM-ODT. 
OCT, and ultrasound can be used in various combinations to 
detect vascular occurrences. 
While the invention has been described in connection with 
various embodiments, it will be understood that the invention 
is capable of further modifications. This application is 
intended to cover any variations, uses or adaptations of the 
invention following, in general, the principles of the inven 
tion, and including Such departures from the present disclo 
Sure as, within the known and customary practice within the 
art to which the invention pertains. 
What is claimed is: 
1. A system for imaging blood vessels, comprising: 
a magnetic field generator configured to produce an oscil 
lating magnetic field to be applied to the blood vessels to 
be imaged, wherein the oscillating magnetic field being 
greater than or equal to 0.14 T at a time during each 
oscillatory cycle and the magnetic field is oscillating at a 
rate greater than or equal to 50 Hz to magnetically move 
hemoglobin, and 
an optical coherence tomography apparatus configured to 
detect magnetic movement of hemoglobin within the 
blood vessels. 
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2. The system of claim 1, further comprising an ultrasound 
imaging System. 
3. The system of claim 1, wherein the magnetic field gen 
erator comprises a Solenoid coil with a ferrite core. 
4. The system of claim 3, wherein the optical coherence 
tomography apparatus further comprises a sample arm, and 
wherein a probe is coupled to the sample arm of the optical 
coherence tomography apparatus and the magnet. 
5. The system of claim 4, wherein the optical coherence 
tomography apparatus is a magneto-motive optical Doppler 
tomography imaging system for detecting the blood flow 
affected by the magnetic field of an at least 100 Hz, Doppler 
frequency shift. 
6. The system of claim 5, wherein the magneto-motive 
optical Doppler tomography system comprises: 
a light source generating light energy, 
an interferometer coupled to the light energy, wherein the 
interferometer includes a reference and sample light 
paths coupled to a light splitter, 
a modulator coupled to the interferometer for modulating 
the optical path length difference in the reference arm 
and the sample arm; 
a scanner coupled to the sample arm for Scanning a bio 
logical sample: 
a rapid scanning optical delay line coupled to the reference 
arm, 
a photodetector coupled to the interferometer for detecting 
backscattered radiation received by the interferometer 
from the scanner to detect interference fringes; and 
a processor for processing the reflected light energy from 
the reference arm and a magnetic resonance signal 
reflected off of the moving blood flow to produce a 
tomographic image and a tomographic flow velocity 
image. 
7. The system of claim 6, wherein the magneto-motive 
optical Doppler tomography system includes the scanner 
with at least two galvanometers to permit three dimensional 
SCaS. 
8. The system of claim 7, wherein the magneto-motive 
optical Doppler tomography system includes a dual-balanced 
photodetector. 
9. The system of claim 8, wherein the magneto-motive 
optical Doppler tomography system includes a circulator 
coupled to the interferometer and the photodetector. 
10. The apparatus of claim 4, wherein the optical coherence 
tomography system for detecting blood flow is a spectral 
domain phase sensitive optical coherence tomography sys 
tem. 
11. The apparatus of claim 10, wherein the phase sensitive 
optical coherence tomographic imaging modality is a Swept 
Source phase sensitive optical coherence tomography system. 
12. The apparatus of claim 2, wherein the optical coherence 
tomography apparatus detects the displacement of red blood 
cells driven by the oscillating magnetic field. 
13. The apparatus of claim 4, wherein the probe is oriented 
parallel to the gradient of the magnetic field. 
14. A system for imaging hemoglobin within the blood 
vessels, comprising: 
a magnetic field generator configured to produce an oscil 
lating magnetic field to be applied to the blood vessels to 
be imaged, the oscillating magnetic field having a 













magnetic movement of hemoglobin having a magnetic 
susceptibility of about 11x10; and 
an optical coherence tomography apparatus configured to 
detect magnetic movement of hemoglobin within the 
blood vessels. 
15. The system of claim 14, further comprising an ultra 
Sound imaging System. 
16. The system of claim 14, wherein the magnetic field 
generator comprises a Solenoid coil with a ferrite core. 
17. The system of claim 14, wherein the optical imaging 
apparatus further comprises a sample arm, and wherein a 
probe is coupled to the sample arm of an optical coherence 
tomography apparatus and the magnetic field generator. 
18. The system of claim 14, wherein the optical imaging 
apparatus is a magneto-motive optical Doppler tomography 
imaging system for detecting the blood flow affected by the 
magnetic field. 
19. The system of claim 18, wherein the magneto-motive 
optical Doppler tomography system further comprises: 
a light source generating light energy: 
an interferometer coupled to the light energy, wherein the 
interferometer includes a reference and sample light 
paths coupled to a light splitter, 
a modulator coupled to the interferometer for modulating 
the optical path length difference in the reference arm 
and the sample arm; 
a scanner coupled to the sample arm for scanning a bio 
logical sample: 
a rapid scanning optical delay line coupled to the reference 
arm, 
a photodetector coupled to the interferometer for detecting 
backscattered radiation received by the interferometer 
from the scanner to detect interference fringes; and 
a processor for processing the reflected light energy from 
the reference arm and a magnetic resonance signal 
reflected off of the moving blood flow to produce a 
tomographic image and a tomographic flow velocity 
image. 
20. The system of claim 19, wherein the magneto-motive 
optical Doppler tomography system includes the scanner 
with at least two galvanometers to permit three dimensional 
SCaS. 
21. The system of claim 19, wherein the magneto-motive 
optical Doppler tomography system includes a dual-balanced 
photodetector. 
22. The system of claim 19, wherein the magneto-motive 
optical Doppler tomography system includes a circulator 
coupled to the interferometer and the photodetector. 
23. A system for imaging hemoglobin comprising: 
a magnetic field generator configured to produce an oscil 
lating magnetic field to hemoglobin, wherein the oscil 
lating magnetic field being greater than or equal to 0.14 
T at a time during each oscillatory cycle and the mag 
netic field is oscillating at a rate greater than or equal to 
50 Hz to magnetically move hemoglobin; and 
an imaging apparatus configured to detect magnetic move 
ment of hemoglobin. 
24. The system of claim 23, wherein the imaging system is 
an optical coherence tomography apparatus. 
25. The system of claim 23, further comprising an ultra 
Sound imaging System. 
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